A drug with the SMILES CCOc1ccc(N2C(=O)/C(=C\c3ccc(O)c(OC)c3)S(=O)(=O)C2c2cccc([N+](=O)[O-])c2)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 25.570%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCOc1ccc(N2C(=O)/C(=C\c3ccc(O)c(OC)c3)S(=O)(=O)C2c2cccc([N+](=O)[O-])c2)cc1
CCOc1ccc(N2C(=O)/C(=C\c3ccc(O)c(OC)c3)S(=O)(=O)C2c2cccc([N+](=O)[O-])c2)cc1
(5E)-3-(4-ethoxyphenyl)-5-[(4-hydroxy-3-methoxyphenyl)methylidene]-2-(3-nitrophenyl)-1,1-dioxo-1,3-thiazolidin-4-one